Carnosine

Carnosine

โš ๏ธ Structural Separation Notice

The Ageless Pep Academy is a clinical education property independent from any commerce operation. Any references in this profile to Ageless Peps product SKUs, pricing, or the agelesspeps.com domain are for completeness and transparency; they are not endorsements and do not form part of the clinical education content. Clinicians are responsible for independent verification of any product sourcing decision. The Academy's Medical Director provides editorial oversight only and does not endorse commercial products.

Endogenous dipeptide (beta-alanine + L-histidine) with anti-glycation, antioxidant, pH buffering, and anti-senescence properties; widely used in functional medicine as an anti-aging supplement.

Quick Facts

Property Value
Also Known As L-Carnosine, beta-alanyl-L-histidine, Karnozin
Category Anti-Aging / Functional Medicine
Sequence beta-Ala-His (dipeptide with beta-amino acid)
Molecular Weight ~226.2 Da
Molecular Formula Cโ‚‰Hโ‚โ‚„Nโ‚„Oโ‚ƒ
PubChem CID 305
Administration Oral (supplement)
Typical Dose Range 500-2000 mg/day oral; beta-alanine alternative: 3-6 g/day
Half-Life ~10-30 minutes in plasma (rapidly hydrolyzed by serum carnosinase CN1); intracellular half-life much longer
Storage Room temperature; stable in dry form
FDA Status Not FDA-approved as a drug; sold as a dietary supplement (GRAS)
WADA Status Not prohibited (beta-alanine is also permitted)

Mechanism of Action

Carnosine is the most abundant histidine-containing dipeptide in human skeletal muscle (5-10 mM) and brain (~1 mM). It is synthesized intracellularly by carnosine synthase (CARNS1) from beta-alanine and L-histidine, with beta-alanine as the rate-limiting substrate.

Anti-glycation (primary anti-aging mechanism): Carnosine prevents the formation of advanced glycation end products (AGEs) through multiple mechanisms. It acts as a "sacrificial peptide," reacting with reactive carbonyl species (methylglyoxal, glyoxal, hydroxynonenal) before they can modify long-lived proteins like collagen, hemoglobin, and crystallin. Carnosine can also inhibit early Amadori product formation and may partially reverse existing AGEs. The histidine imidazole ring is critical for this carbonyl-quenching activity (PMID-29858687).

Antioxidant: Carnosine scavenges reactive oxygen species (superoxide, hydroxyl radical, singlet oxygen), chelates redox-active transition metals (Cuยฒโบ, Znยฒโบ, Feยฒโบ) preventing Fenton reactions, and inhibits lipid peroxidation. Its antioxidant activity is complementary to glutathione โ€” carnosine works extracellularly and in specific intracellular compartments where GSH may be less concentrated.

pH buffering: At physiological concentrations in muscle (5-10 mM), carnosine's histidine imidazole ring (pKa ~6.83) provides significant intracellular pH buffering during high-intensity exercise. This delays acidosis-related muscle fatigue. Beta-alanine supplementation (which increases muscle carnosine) is a well-validated ergogenic aid for exercise performance.

Anti-senescence: Carnosine extends the replicative lifespan of cultured human fibroblasts and rejuvenates senescent cells (restoring youthful morphology). The mechanism may involve reducing protein carbonylation and AGE accumulation that drive cellular senescence (PMID-37049610).

The carnosinase challenge: Oral carnosine is rapidly hydrolyzed in plasma by serum carnosinase (CN1), an enzyme with high activity in humans (but low in rodents, complicating translation of animal data). However, the constituent amino acids are taken up by target tissues and used for intracellular carnosine resynthesis. Strategies to overcome this include: higher oral doses, sustained-release formulations, and carnosinase-resistant analogs (anserine, N-acetylcarnosine).

Key Research Areas

  1. Anti-glycation โ€” Systematic review confirms carnosine prevents AGE formation through multiple mechanisms (PMID-29858687)
  2. Anti-aging and senescence โ€” Extends fibroblast lifespan, reduces protein carbonylation, anti-senescence effects (PMID-37049610)
  3. Exercise performance โ€” Beta-alanine supplementation (โ†’ muscle carnosine) improves high-intensity exercise performance (well-supported by meta-analyses)
  4. Diabetes โ€” Anti-glycation effects relevant to diabetic complications (nephropathy, retinopathy)
  5. Neuroprotection โ€” Reduces protein aggregation relevant to Alzheimer's, Parkinson's; protects against excitotoxicity
  6. Wound healing โ€” Zinc-carnosine (polaprezinc) is approved in Japan for gastric ulcers

Evidence Level Summary

Evidence Type Count Notes
Human RCTs Several Primarily beta-alanine for exercise; carnosine for diabetes, cognitive
Systematic reviews 2+ AGE formation, exercise performance (beta-alanine)
Human observational Several Carnosine levels in aging, T2D
Animal in vivo Extensive Anti-aging, neuroprotection, diabetes models
In vitro Extensive Anti-glycation, antioxidant, anti-senescence

Clinical Applications

  • Anti-Aging โ€” Anti-glycation, anti-senescence, antioxidant
  • Type 2 Diabetes โ€” AGE prevention, diabetic complication reduction
  • Neuroprotection โ€” Protein aggregation inhibition
  • Gut Health โ€” Zinc-carnosine for gastric protection (polaprezinc)

Protocols Using This Peptide

Ageless Peps Products

Carnosine is NOT currently sold by Ageless Peps. It is included in this vault as a functional medicine reference frequently used alongside peptide therapy.

Dosing Reference

Supplementation Dosing Ranges

Route Dose Range Frequency Duration Source
Oral (L-carnosine) 500-2000 mg Daily (divided 2x) Ongoing Clinical practice
Oral (beta-alanine) 3.2-6.4 g Daily (divided 4x to reduce paresthesia) 4-12+ weeks Meta-analyses
Oral (zinc-carnosine) 75-150 mg Daily (divided 2x) 8+ weeks GI applications

Cycling

Not typically cycled for anti-aging use โ€” ongoing daily supplementation. Beta-alanine for exercise: muscle carnosine loading requires 4-10 weeks, with washout over 6-15 weeks after cessation. Paresthesia (tingling) from beta-alanine is harmless and dose-related.

Contraindications & Safety

  • Contraindications: None known for oral carnosine at recommended doses
  • Common side effects: Oral carnosine: generally very well-tolerated. Beta-alanine: transient paresthesia (face, hands) โ€” harmless, dose-related, reduced with divided dosing
  • Drug interactions: No significant known drug interactions; theoretical interaction with carnosine and zinc (zinc-carnosine used therapeutically)
  • Pregnancy/nursing: Endogenous molecule; limited formal study of supplementation during pregnancy
  • Special populations: Serum carnosinase (CN1) activity varies genetically; individuals with low CN1 activity may have better oral bioavailability

Synergistic Combinations

  • Glutathione + Carnosine โ€” Complementary antioxidant mechanisms (GSH: thiol-based ROS scavenging; carnosine: carbonyl quenching/metal chelation)
  • NAD+ + Carnosine โ€” NAD+ for sirtuin activation/energy; carnosine for AGE prevention/anti-senescence
  • GHK-Cu + Carnosine โ€” GHK-Cu for gene expression remodeling; carnosine for anti-glycation (complementary anti-aging)
  • Carnosine + Alpha-lipoic acid โ€” Both target AGE formation through different mechanisms

Related Research

PMID Title Year Study Type
29858687 Carnosine and AGEs: Systematic Review 2018 Systematic Review
37049610 Carnosine and Beta-Alanine Supplementation Review 2023 Narrative Review

References

  • PMID-29858687 โ€” Baye et al., Carnosine and AGEs systematic review, Amino Acids 2018
  • PMID-37049610 โ€” Prokopieva et al., Carnosine supplementation review, Nutrients 2023

Related

Note: Carnosine is not a traditional peptide therapeutic but is widely used in functional medicine as an anti-aging supplement. As an endogenous dipeptide with well-characterized anti-glycation, antioxidant, and anti-senescence properties, it provides a mechanistically rational complement to peptide therapy protocols.

#peptide #anti-aging #not-sold #oral #functional-medicine